Adalimumab for Mooren's Ulcer

Ophthalmology

Volumn 116, Issue 8, 2009, Pages

  Cordero Coma, Miguel ^a   Benito, Manuel Franco ^a   Fuertes, Carlos Lobato ^a   Antolín, Sara Calleja ^a   García Ruíz, José M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CYCLOPHOSPHAMIDE;

ADULT; AMNION; ANAMNESIS; ANTERIOR EYE SEGMENT; ANTIGEN ANTIBODY COMPLEX; CASE REPORT; CHEMOTAXIS; CONTACT LENS; CORNEA RODENT ULCER; CORNEA ULCER; DESCEMET MEMBRANE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EYE EXAMINATION; EYE INFLAMMATION; FEMALE; HUMAN; INFLAMMATORY CELL; LETTER; LOADING DRUG DOSE; PRIORITY JOURNAL; TREATMENT DURATION; VISUAL ACUITY;

EID: 68049086890     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2009.03.019     Document Type: Letter

References (7)

1. Srinivasan M., Zegans M.E., Zelefsky J.R., et al. Clinical characteristics of Mooren's ulcer in South India. Br J Ophthalmol 91 (2007) 570-575
2. Foster C.S. Mooren's ulcer. In: Foster C.S., Azar D.T., and Dohlman C.H. (Eds). Smolin and Thoft's: The Cornea, Scientific Foundations and Clinical Practice. 4th ed. (2005), Lippincott, Williams & Wilkins, Philadelphia 551-557
3. Lambiase A., Sacchetti M., Sgrulletta R., et al. Amniotic membrane transplantation associated with conjunctival peritomy in the management of Mooren's ulcer: a case report. Eur J Ophthalmol 15 (2005) 274-276
4. Foster C.S. Systemic immunosuppressive therapy for progressive bilateral Mooren's ulcer. Ophthalmology 92 (1985) 1436-1439
5. Saw V.P., Cornelius N., Salama A.D., et al. Infliximab therapy for aggressive mooren ulceration. Arch Ophthalmol 126 (2008) 734
6. Anderson P.J. Tumor necrosis factor inhibitors: clinical implications of their different immunogenicity profiles. Semin Arthritis Rheum 34 5 Suppl1 (2005) 19-22
7. Chilton F., and Collett R.A. Treatment choices, preferences and decision-making by patients with rheumatoid arthritis. Musculoskeletal Care 6 (2008) 1-14